Loading...
Market
Will a new pertussis vaccine be developed by a major pharmaceutical company by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases from pharmaceutical companies and CDC updates
Story
CDC Recommends Seven COVID-19 Vaccine Doses for Babies by Six Months, Including Pertussis, Under RFK's Potential Changes
Nov 25, 2024, 01:10 PM
The Centers for Disease Control and Prevention (CDC) has recommended that babies receive seven doses of the COVID-19 vaccine by the age of six months to be considered fully up to date on their vaccinations. This guidance has raised questions about future vaccination messaging, particularly in light of potential changes under Robert F. Kennedy Jr. (RFK). In addition to COVID-19, the CDC also advises routine vaccinations for infants at 2, 4, and 6 months of age, including for pertussis. Parents are encouraged to stay informed about vaccination schedules for their children, especially those under five years old, as the CDC continues to update its recommendations.
View original story
Similar markets
Johnson & Johnson • 25%
AstraZeneca • 25%
Sanofi • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Influenza • 25%
Zika • 25%
HIV • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%